{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:12:39Z","timestamp":1788361959951,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sarcoma of unknown primary (SUP) designates an enigmatic entity with histologic confirmation of a metastatic tumor without an identifiable primary after a thorough diagnostic workup. The term \u201cunknown primary\u201d is heavily debatable given that sarcomas can arise from any tissue that harbors its histological structure. In this review, we discuss the validity of SUP as a distinct entity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body of the abstract<\/jats:title>\n                <jats:p>Medline\/PubMed and Google Scholar were searched from 1990 until April 2020 for publications in the English language reporting on SUP. We excluded articles reporting on cases with sarcomas from known organ sites such as lung or uterine sarcomas as well as synovial sarcomas. The Kaplan\u2013Meier method was used to compute the median overall survival. A total of 26 patients with SUP were identified. The median age at diagnosis was 17.5 years with a similar prevalence among men and women. The tumors most commonly reported were alveolar rhabdomyosarcoma and rhabdomyosarcoma not otherwise specified. Almost two-thirds of the patients were reported to have more than one metastatic site. Among the 13 patients with survival data, the median overall survival was 10.0 months. Two patients underwent autopsy and had their primary culprit identified in the chest wall and paravertebral.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This review showed that SUP shares with sarcomas of known primary similar clinical features including an aggressive clinical course, generally poor response to chemotherapy, and dismal patient outcomes. Thus, SUP does not appear to display a different natural history and biological properties that would allude to a distinct entity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43046-022-00128-1","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:02:22Z","timestamp":1656288142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sarcoma of unknown primary: myth or reality?"],"prefix":"10.1186","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-0991","authenticated-orcid":false,"given":"Elie","family":"Rassy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosy","family":"Abou-Jaoude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios","family":"Boussios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Assi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"issue":"3","key":"128_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"128_CR2","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41568-020-0288-4","volume":"20","author":"BA Nacev","year":"2020","unstructured":"Nacev BA, Jones KB, Intlekofer AM, Yu JSE, Allis CD, Tap WD, et al. The epigenomics of sarcoma. Nat Rev Cancer. 2020;20(10):608\u201323.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"128_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc1168","volume":"3","author":"LJ Helman","year":"2003","unstructured":"Helman LJ, Meltzer P. Mechanisms of sarcoma development. Nat Rev Cancer. 2003;3(9):685\u201394.","journal-title":"Nat Rev Cancer"},{"issue":"9824","key":"128_CR4","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0140-6736(11)61178-1","volume":"379","author":"N Pavlidis","year":"2012","unstructured":"Pavlidis N, Pentheroudakis G. Cancer of unknown primary site. Lancet. 2012;379(9824):1428\u201335.","journal-title":"Lancet"},{"issue":"9","key":"128_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/14737140.2020.1807948","volume":"20","author":"E Rassy","year":"2020","unstructured":"Rassy E, Pavlidis N. The diagnostic challenges of patients with carcinoma of unknown primary. Expert Rev Anticancer Ther. 2020;20(9):775\u201383.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"6","key":"128_CR6","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.amjsurg.2007.08.039","volume":"194","author":"JM Pimiento","year":"2007","unstructured":"Pimiento JM, Teso D, Malkan A, Dudrick SJ, Palesty JA. Cancer of unknown primary origin: a decade of experience in a community-based hospital. Am J Surg. 2007;194(6):833\u20137 discussion 837-838.","journal-title":"Am J Surg"},{"issue":"2","key":"128_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1158\/2159-8290.CD-14-1246","volume":"5","author":"TO Nielsen","year":"2015","unstructured":"Nielsen TO, Poulin NM, Ladanyi M. Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy. Cancer Discov. 2015;5(2):124\u201334.","journal-title":"Cancer Discov"},{"issue":"1","key":"128_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/PAP.0000000000000284","volume":"28","author":"JH Choi","year":"2021","unstructured":"Choi JH, Ro JY. The 2020 WHO classification of tumors of soft tissue: selected changes and new entities. Adv Anat Pathol. 2021;28(1):44\u201358.","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"128_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/1097-0142(19860101)57:1<120::AID-CNCR2820570124>3.0.CO;2-M","volume":"57","author":"E Altman","year":"1986","unstructured":"Altman E, Cadman E. An analysis of 1539 patients with cancer of unknown primary site. Cancer. 1986;57(1):120\u20134.","journal-title":"Cancer"},{"issue":"13","key":"128_CR10","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/S0959-8049(02)00135-1","volume":"38","author":"F Levi","year":"2002","unstructured":"Levi F, Te VC, Erler G, Randimbison L, La Vecchia C. Epidemiology of unknown primary tumours. Eur J Cancer. 2002;38(13):1810\u20132.","journal-title":"Eur J Cancer"},{"key":"128_CR11","doi-asserted-by":"publisher","first-page":"v133","DOI":"10.1093\/annonc\/mdv305","volume":"26","author":"K Fizazi","year":"2015","unstructured":"Fizazi K, Greco FA, Pavlidis N, Daugaard G, Oien K, Pentheroudakis G. Cancers of unknown primary site: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2015;26:v133\u20138.","journal-title":"Ann Oncol"},{"issue":"9","key":"128_CR12","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1093\/annonc\/mdr610","volume":"23","author":"I Ray-Coquard","year":"2012","unstructured":"Ray-Coquard I, Montesco MC, Coindre JM, Dei Tos AP, Lurkin A, Ranch\u00e8re-Vince D, et al. Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions. Ann Oncol sept. 2012;23(9):2442\u20139.","journal-title":"Ann Oncol sept"},{"issue":"3","key":"128_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000326550","volume":"47","author":"DJ Facundo","year":"2003","unstructured":"Facundo DJ, Quinonez G, Ravinsky E. Transmission electron microscopy of fine needle aspiration biopsies of metastases. Accuracy of both techniques as established by biopsy diagnoses. Acta Cytol. 2003;47(3):457\u201362.","journal-title":"Acta Cytol"},{"issue":"11","key":"128_CR14","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","volume":"32","author":"A Gronchi","year":"2021","unstructured":"Gronchi A, Miah AB, Tos APD, Abecassis N, Bajpai J, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO\u2013EURACAN\u2013GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2021;32(11):1348\u201365.","journal-title":"Ann Oncol"},{"issue":"2","key":"128_CR15","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1177\/000313481608200202","volume":"82","author":"ZM DeBoard","year":"2016","unstructured":"DeBoard ZM, West PN. Pulmonary synovial sarcoma of unknown origin. Am Surg. 2016;82(2):E40\u20132.","journal-title":"Am Surg"},{"issue":"12","key":"128_CR16","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.ejso.2019.08.015","volume":"45","author":"G Zhang","year":"2019","unstructured":"Zhang G, Xiao B, Huang H, Zhang Y, Zhang X, Zhang J, et al. Intracranial synovial sarcoma: a clinical, radiological and pathological study of 16 cases. Eur J Surg Oncol d\u00e9c. 2019;45(12):2379\u201385.","journal-title":"Eur J Surg Oncol d\u00e9c"},{"issue":"1","key":"128_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12916-017-0831-7","volume":"15","author":"M Savina","year":"2017","unstructured":"Savina M, Le Cesne A, Blay J-Y, Ray-Coquard I, Mir O, Toulmonde M, et al. Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study. BMC Med. 2017;15(1):78.","journal-title":"BMC Med"},{"issue":"7","key":"128_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41571-018-0012-4","volume":"15","author":"A Dufresne","year":"2018","unstructured":"Dufresne A, Brahmi M, Karanian M, Blay J-Y. Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours. Nat Rev Clin Oncol. 2018;15(7):443\u201358.","journal-title":"Nat Rev Clin Oncol"},{"key":"128_CR19","doi-asserted-by":"crossref","unstructured":"Assi T, Rassy E, Nassereddine H, Farhat F, Kattan J. Epithelioid sarcoma as the prototype for personalized therapy in soft tissue sarcoma. Per Med. 2020;17(4):241-4.","DOI":"10.2217\/pme-2020-0006"},{"key":"128_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ctrv.2018.11.003","volume":"72","author":"T Assi","year":"2019","unstructured":"Assi T, Kattan J, El Rassy E, Honore C, Dumont S, Mir O, et al. A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcoma. Cancer Treat Rev. 2019;72:37\u201344.","journal-title":"Cancer Treat Rev"},{"key":"128_CR21","doi-asserted-by":"crossref","unstructured":"Assi T, Kattan J, Rassy E, Nassereddine H, Farhat F, Honore C, Le Cesne A, Adam J, Mir O. Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review. Crit Rev Oncol Hematol. 2020;153:103029.","DOI":"10.1016\/j.critrevonc.2020.103029"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-022-00128-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-022-00128-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-022-00128-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:02:56Z","timestamp":1656288176000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-022-00128-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["128"],"URL":"https:\/\/doi.org\/10.1186\/s43046-022-00128-1","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Professor Hussein Khaled is a co-author of this study and Editor-in-Chief for the journal. He declares a competing interest for this submission. He was not involved in handling this manuscript during the submission and review processes. The rest of the authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}